NCT00509691
- Conditions
- Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +109 more
- Locations
-
- Penn State Hershey Cancer Institute at Milton S. Hershey Medical Center Hershey, Pennsylvania, United States
Clinical trial condition
Sezary Syndrome
Explore clinical trials studying Sezary Syndrome. Study availability and eligibility vary by location and protocol.
262 public trials
17 recruiting studies
Sezary Syndrome trial results
Completed
Aprepitant in Preventing Nausea and Vomiting in Patients Who Are Undergoing a Stem Cell Transplant
NCT00248547
- Conditions
- Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +100 more
- Locations
-
- OHSU Knight Cancer Institute Portland, Oregon, United States
Completed
Methemoglobinemia in Young Patients With Hematologic Cancer or Aplastic Anemia Treated With Dapsone
NCT00993694
- Conditions
- Amyloidosis, Anemia, Anemia, Aplastic, +101 more
- Locations
-
- Vanderbilt-Ingram Cancer Center - Cool Springs Nashville, Tennessee, United States
- Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States
Completed
Oral SAHA (Suberoylanilide Hydroxamic Acid) in Advanced Cutaneous T-cell Lymphoma (0683-001)
NCT00091559
- Conditions
- Cutaneous T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
- Locations
-
Not specified
Completed
Brentuximab Vedotin (SGN-35) in Patients With Mycosis Fungoides With Variable CD30 Expression Level
NCT01396070
- Conditions
- Cutaneous Lymphoma, Cutaneous T-cell Lymphoma (CTCL), Hemic and Lymphatic Diseases, +13 more
- Locations
-
- Stanford University School of Medicine Stanford, California, United States
NCT00897923
- Conditions
- Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +50 more
- Locations
-
- Holden Comprehensive Cancer Center at University of Iowa Iowa City, Iowa, United States
- Mayo Clinic Cancer Center Rochester, Minnesota, United States
NCT00408681
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Adnexal Diseases, Adult Acute Lymphoblastic Leukemia in Remission, +221 more
- Locations
-
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
NCT00416624
- Conditions
- Amyloidosis, Anemia, Blood Protein Disorders, +72 more
- Locations
-
- Mayo Clinic Rochester, Minnesota, United States
NCT00719563
- Conditions
- Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +103 more
- Locations
-
- Mayo Clinic Scottsdale Scottsdale, Arizona, United States
- Aurora Presbyterian Hospital Aurora, Colorado, United States
- Boulder Community Hospital Boulder, Colorado, United States
- Penrose Cancer Center at Penrose Hospital Colorado Springs, Colorado, United States
Completed
A-dmDT390-bisFv(UCHT1) Immunotoxin Therapy for Patients With Cutaneous T-Cell Lymphoma (CTCL)
NCT00611208
- Conditions
- Cutaneous T-cell Lymphoma (CTCL), Hematologic Diseases, Hemic and Lymphatic Diseases, +17 more
- Locations
-
- Yale University School Of Medicine Recruiting New Haven, Connecticut, United States
- James Graham Brown Cancer Center Louisville, Kentucky, United States
- University of Texas Southwestern Medical Center Dallas, Texas, United States
- University of Texas MD Anderson Cancer Center Houston, Texas, United States